We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temporally Splitting Ovarian Stimulation and Embryo Transfer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00795041
First Posted: November 21, 2008
Last Update Posted: October 18, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Luebeck
  Purpose
The purpose of this study is to explore the concept of temporally splitting ovarian stimulation and embryo transfer.

Condition
Splitting of Ovarianstimulation and Embryotransfer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Temporally Splitting Ovarian Stimulation and Embryo Transfer

Further study details as provided by University of Luebeck:

Primary Outcome Measures:
  • Ongoing pregnancy rate [ Time Frame: November 2008- May 2009 ]

Enrollment: 10
Study Start Date: November 2008
Study Completion Date: September 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
10 women with indication for ART with ICSI or IVF

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 36 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
women with indication for ART with ICSI or IVF
Criteria

Inclusion Criteria:

  • Indication for IVF/ICSI
  • Age 18-36 years
  • <= three earlier unsuccessful IVF/ICSI treatments with embryo transfer
  • BMI 20-30
  • Regular cycle with ovulation (28-35 days)
  • Progesterone >7ng/ml at the beginning of stimulation
  • Informed consents

Exclusion Criteria:

  • PCOS (polycystic ovarian syndrome
  • Endometrioses >= grade 3
  • Known poor response syndrome
  • History of ovariectomy
  • Severe endocrinopathie
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00795041


Locations
Germany
University Hospital of Schleswig Holstein, Campus Luebeck, Department of Obstetrics and Gynecology
Luebeck, Schleswig-Holstein, Germany, 23538
Sponsors and Collaborators
University of Luebeck
Investigators
Principal Investigator: Georg Griesinger, PD MD University of Schleswig-Holstein, Campus Luebeck, Department of Obstetrics and Gynecology
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Buendgen N.; Griesinger G. PD Dr. med., University Hospital of SH, Campus Luebeck, Deparment of Obstetrics/Gynecology
ClinicalTrials.gov Identifier: NCT00795041     History of Changes
Other Study ID Numbers: TS1
First Submitted: November 20, 2008
First Posted: November 21, 2008
Last Update Posted: October 18, 2010
Last Verified: November 2008

Keywords provided by University of Luebeck:
vitrification
ovarian stimulation
reproductive medicine